Edwards Lifesciences (EW) Non-Current Assets (2009 - 2026)

Edwards Lifesciences' Non-Current Assets history runs 18 years deep, the most recent figure standing at $7.1 billion for Q1 2026.

• In Q1 2026, Non-Current Assets rose 4.15% year-over-year to $7.1 billion; the TTM figure through Mar 2026 stood at $27.9 billion (up 9.72% YoY), while the FY2025 annual figure was $7.0 billion, up 2.78% from the prior year.
• Non-Current Assets was $7.1 billion for Q1 2026 at Edwards Lifesciences, up from $7.0 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $7.1 billion in Q1 2026 to a low of $5.1 billion in Q3 2022.
• Historically, Non-Current Assets has averaged $5.9 billion across 5 years, with a median of $5.6 billion in 2024.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets dropped 2.35% in 2022, then rose 27.07% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $5.2 billion in 2022, then increased by 2.52% to $5.3 billion in 2023, then advanced by 27.07% to $6.8 billion in 2024, then rose by 2.78% to $7.0 billion in 2025, then rose by 1.93% to $7.1 billion in 2026.
• The last three Non-Current Assets figures came in at $7.1 billion (Q1 2026), $7.0 billion (Q4 2025), and $6.9 billion (Q3 2025), per Business Quant data.